<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pediatric Hematology/Oncology and Immunopathology</journal-id><journal-title-group><journal-title xml:lang="en">Pediatric Hematology/Oncology and Immunopathology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы гематологии/онкологии и иммунопатологии в педиатрии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-1708</issn><issn publication-format="electronic">2414-9314</issn><publisher><publisher-name xml:lang="en">Fund Doctors, Innovations, Science for Children</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">54</article-id><article-id pub-id-type="doi">10.24287/1726-1708-2017-16-2-45-49</article-id><article-categories><subj-group subj-group-type="toc-heading"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Pediatric clinical case of parameningeal undifferentiated pleomorphic sarcoma treated with chemoradiotherapy</article-title><trans-title-group xml:lang="ru"><trans-title>Клинический случай химиолучевой терапии недифференцированной плеоморфной саркомы параменингеальной локализации у ребенка</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8313-9056</contrib-id><name-alternatives><name xml:lang="en"><surname>Usychkina</surname><given-names>A. Y.</given-names></name><name xml:lang="ru"><surname>Усычкина</surname><given-names>А. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, pediatric oncologist Department of Radiation Therapy</p><p>Russia 117997, Moscow, Samory Mashela st., 1 Tel.: +7 (916)-695-0460</p></bio><bio xml:lang="ru"><p>врач – детский онколог отделения лучевой терапии ННПЦ детской гематологии</p><p>117997, Москва, ГСП-7, ул. Саморы Машела, 1 Тел.: +7 (916)-695-0460</p></bio><email>usychkina@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kobyzeva</surname><given-names>D. A.</given-names></name><name xml:lang="ru"><surname>Кобызева</surname><given-names>Д. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gornostaev</surname><given-names>V. V.</given-names></name><name xml:lang="ru"><surname>Горностаев</surname><given-names>В. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Loginova</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Логинова</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3704-8783</contrib-id><name-alternatives><name xml:lang="en"><surname>Kachanov</surname><given-names>D. Y.</given-names></name><name xml:lang="ru"><surname>Качанов</surname><given-names>Д. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Varfolomeeva</surname><given-names>S. R.</given-names></name><name xml:lang="ru"><surname>Варфоломеева</surname><given-names>С. Р.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Roshin</surname><given-names>V. Y.</given-names></name><name xml:lang="ru"><surname>Рощин</surname><given-names>В. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Nechesnyuk</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Нечеснюк</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">National Scientific and Practical Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный научно-практический центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева» Минздрава России, Москва</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-06-10" publication-format="electronic"><day>10</day><month>06</month><year>2017</year></pub-date><volume>16</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>45</fpage><lpage>49</lpage><history><date date-type="received" iso-8601-date="2018-08-10"><day>10</day><month>08</month><year>2018</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2017, «D. Rogachev NMRCPHOI»</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2017, ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="en">«D. Rogachev NMRCPHOI»</copyright-holder><copyright-holder xml:lang="ru">ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://hemoncim.com/jour/article/view/54">https://hemoncim.com/jour/article/view/54</self-uri><abstract xml:lang="en"><p>Malignant fibrous histiocytoma (MFH) is a rare “NON-RMS-LIKE” pediatric tumor with highly malignant clinical behavior, high metastatic potential and overall 5-year survival around 65-70%. Soft tissue  sarcoma diagnostic work-up and optimal combination of systemic therapy and local therapy approaches are one of  the most challenging issues in modern pediatric oncology. To present a clinical case of parameningeal  undifferentiated pleomorphic sarcoma in 7-year old child treated with adaptive conformal radiotherapy  aimed at local tumor control. We describe a method of combined treatment of patient with parameningeal  UPS consisting of the intensity-modulated radiotherapy (IMRT) in the form of volumetrically-modulated arc- therapy (VMAT) aimed at local tumor control. The radiotherapy course was completed at the planned total  dose of 54 Gy. Acute skin and mucosal toxicity not more than Grade 2 (RTOG scale) was noted during the  treatment. A good partial response was recorded after chemoradiotherapy course had been finished.  Histological verification of UPS diagnosis is complicated as substantial amount of tumor tissue material is  required for immunohistochemical and cytogenetical studies. An aggressive surgical approach is a method  of choice for local control in parameningeal soft-tissue sarcomas. However the adaptive radiotherapy was  the only possible treatment method of local tumor control with significant decrease of high doses to adjacent normal organs and tissues.</p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>Intensity-modulated radiotherapy (IMRT) in children</kwd><kwd>VMAT</kwd><kwd>soft-tissue sarcomas in children</kwd><kwd>parameningeal malignant fibrous histiocytoma</kwd><kwd>undifferentiated pleomorphic sarcoma</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>лучевая терапия с модуляцией интенсивности (IMRT) у детей</kwd><kwd>VMAT</kwd><kwd>саркомы мягких тканей у детей</kwd><kwd>злокачественная фиброзная гистиоцитома параменингеальной локализации</kwd><kwd>недифференцированная плеоморфная саркома</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Radzikowska J., Kukwa W., Kukwa A., Czarnecka A., Krzeski A. Rhabdom-yosarcoma of the head and neck in children. Contemp Oncol (Pozn) 2015; 19 (2): 98-107.</mixed-citation><mixed-citation xml:lang="ru">Radzikowska J., Kukwa W., Kukwa A., Czarnecka A., Krzeski A. Rhabdom-yosarcoma of the head and neck in children. Contemp Oncol (Pozn) 2015; 19 (2): 98-107.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Chang R.C., Dave S.P., Robinson P.G. Undifferentiated pleomorphic sarcoma of the parotid gland: A rare pediatric case. Head Neck 2008; 30 (7): 970-3.</mixed-citation><mixed-citation xml:lang="ru">Chang R.C., Dave S.P., Robinson P.G. Undifferentiated pleomorphic sarcoma of the parotid gland: A rare pediatric case. Head Neck 2008; 30 (7): 970-3.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Clark D.W., Moore B.A., Patel S.R., Guadagnolo B.A., Roberts D.B., Sturgis E.M. Malignant fibrous histiocytoma of the head and neck region. Head Neck 2011; 33 (3): 303-8.</mixed-citation><mixed-citation xml:lang="ru">Clark D.W., Moore B.A., Patel S.R., Guadagnolo B.A., Roberts D.B., Sturgis E.M. Malignant fibrous histiocytoma of the head and neck region. Head Neck 2011; 33 (3): 303-8.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Alaggio R., Collini P., Randall R.L., Barnette P., Million L., Coffin C.M. Undifferen-tiated high-grade pleomorphic sarcomas in children: A clinicopathologic study of 10 cases and review of literature. Pediatr Dev Pathol 2010; 13 (3): 209-17.</mixed-citation><mixed-citation xml:lang="ru">Alaggio R., Collini P., Randall R.L., Barnette P., Million L., Coffin C.M. Undifferen-tiated high-grade pleomorphic sarcomas in children: A clinicopathologic study of 10 cases and review of literature. Pediatr Dev Pathol 2010; 13 (3): 209-17.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Paulino A.C., Fowler B.Z. Secondary neoplasms after radiotherapy for a childhood solid tumor. Pediatr Hematol Oncol 2005 Mar; 22 (2): 89-101.</mixed-citation><mixed-citation xml:lang="ru">Paulino A.C., Fowler B.Z. Secondary neoplasms after radiotherapy for a childhood solid tumor. Pediatr Hematol Oncol 2005 Mar; 22 (2): 89-101.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Mohan R.P., Verma S., Siddhu V.K., Agarwal N. Malignant fibrous histiocytoma. BMJ Case Rep 2013 (31): 2013.</mixed-citation><mixed-citation xml:lang="ru">Mohan R.P., Verma S., Siddhu V.K., Agarwal N. Malignant fibrous histiocytoma. BMJ Case Rep 2013 (31): 2013.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Rosenberg A.E. Malignant fibrous histiocytoma: Past, present, and future. Skeletal Radiol 2003; 32 (11): 613-8.</mixed-citation><mixed-citation xml:lang="ru">Rosenberg A.E. Malignant fibrous histiocytoma: Past, present, and future. Skeletal Radiol 2003; 32 (11): 613-8.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Fletcher C.D. The evolving classification of soft tissue tumours - an update based on the new 2013 WHO classification. Histopathology 2014; 64 (1): 2-11.</mixed-citation><mixed-citation xml:lang="ru">Fletcher C.D. The evolving classification of soft tissue tumours - an update based on the new 2013 WHO classification. Histopathology 2014; 64 (1): 2-11.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Ding G.X., Duggan D.M., Coffey C.W., Deeley M., Hallahan D.E., Cmelak A., Malcolm A. A study on adaptive IMRT treatment planning using kv cone-beam CT. Radiother Oncol 2007 Oct; 85 (1): 116-25.</mixed-citation><mixed-citation xml:lang="ru">Ding G.X., Duggan D.M., Coffey C.W., Deeley M., Hallahan D.E., Cmelak A., Malcolm A. A study on adaptive IMRT treatment planning using kv cone-beam CT. Radiother Oncol 2007 Oct; 85 (1): 116-25.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Brouwer C.L., Steenbakkers R.J., Bourhis J., Budach W., Grau C., Grégoire V., et al. CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG oncology and TROG consensus guidelines. Radiother Oncol 2015 Oct; 117 (1): 83-90</mixed-citation><mixed-citation xml:lang="ru">Brouwer C.L., Steenbakkers R.J., Bourhis J., Budach W., Grau C., Grégoire V., et al. CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG oncology and TROG consensus guidelines. Radiother Oncol 2015 Oct; 117 (1): 83-90</mixed-citation></citation-alternatives></ref></ref-list></back></article>
